The Rare Kidney Stone Consortium, Mayo Clinic, Rochester, MN, USA.
Pediatr Nephrol. 2013 Oct;28(10):1923-42. doi: 10.1007/s00467-012-2329-z. Epub 2013 Jan 20.
Adenine phosphoribosyltransferase (APRT) deficiency, cystinuria, Dent disease, familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), and primary hyperoxaluria (PH) are rare but important causes of severe kidney stone disease and/or chronic kidney disease in children. Recurrent kidney stone disease and nephrocalcinosis, particularly in pre-pubertal children, should alert the physician to the possibility of an inborn error of metabolism as the underlying cause. Unfortunately, the lack of recognition and knowledge of the five disorders has frequently resulted in an unacceptable delay in diagnosis and treatment, sometimes with grave consequences. A high index of suspicion coupled with early diagnosis may reduce or even prevent the serious long-term complications of these diseases. In this paper, we review the epidemiology, clinical features, diagnosis, treatment, and outcome of patients with APRT deficiency, cystinuria, Dent disease, FHHNC, and PH, with an emphasis on childhood manifestations.
腺嘌呤磷酸核糖基转移酶 (APRT) 缺陷、胱氨酸尿症、Dent 病、家族性低镁血症伴高钙尿和肾钙质沉着症 (FHHNC) 和原发性高草酸尿症 (PH) 是儿童严重肾结石病和/或慢性肾脏病的罕见但重要病因。复发性肾结石病和肾钙质沉着症,特别是在青春期前儿童中,应引起医生注意,可能是潜在代谢紊乱的病因。不幸的是,对这五种疾病的认识和了解不足,经常导致诊断和治疗的不可接受的延迟,有时后果严重。高度怀疑并早期诊断可能会减少甚至预防这些疾病的严重长期并发症。本文综述了 APRT 缺陷、胱氨酸尿症、Dent 病、FHHNC 和 PH 患者的流行病学、临床特征、诊断、治疗和结局,重点介绍了儿童期表现。